A global view of hypertensive disorders and diabetes mellitus during pregnancy

Li Jiang1, Kun Tang1,2, Laura A Magee3

  • 1Centre for Global Child Health, The Hospital for Sick Children, Toronto, Canada.

Insights

Maternal cardiometabolic disorders like hypertensive disorders in pregnancy (HDP) and gestational diabetes mellitus (GDM) disproportionately affect low-income regions. Addressing these conditions requires a multilevel approach beyond individual care to combat health inequities.

Area of Science:

  • Obstetrics and Gynecology
  • Cardiology
  • Endocrinology
  • Public Health

Background:

  • Maternal cardiometabolic disorders (CMDs), including hypertensive disorders in pregnancy (HDP) and gestational diabetes mellitus (GDM), represent a significant global health burden.
  • Lack of standardized diagnostic criteria for HDP and GDM complicates accurate assessment of disease burden across diverse regions.
  • These disorders disproportionately impact low- and middle-income countries (LMICs) and populations with lower sociodemographic and human development indexes.

Purpose of the Study:

  • To highlight the global disease burden of maternal cardiometabolic disorders (CMDs).
  • To emphasize the influence of social determinants of health and systemic marginalization on maternal CMDs.
  • To advocate for a multilevel approach and multisectoral partnerships to address health inequities related to maternal CMDs.

Main Methods:

  • Review of existing literature on the epidemiology and management of HDP and GDM.
  • Analysis of the impact of social determinants of health on maternal CMDs.
  • Discussion of current challenges in screening and management, including disruptions from the COVID-19 pandemic.

Main Results:

  • Maternal CMDs exhibit an uneven disease burden, particularly in LMICs.
  • Social determinants of health significantly influence the development and consequences of maternal CMDs.
  • The accuracy and long-term effects of screening and management programs require further investigation.

Conclusions:

  • A comprehensive, multilevel strategy involving multisectoral partnerships is essential to address the public health issues and health inequities stemming from maternal CMDs.
  • Women with maternal CMDs are particularly vulnerable during public health crises like the COVID-19 pandemic.
  • Further research is needed to refine screening and management protocols for HDP and GDM.

Related Concept Videos

Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.7K
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
1.2K
Hypertension V: Nursing Management01:23

Hypertension V: Nursing Management

The nursing management of hypertension involves accurately assessing symptoms, making a comprehensive nursing diagnosis, collaborating with patients to set goals, and implementing targeted interventions to mitigate the condition's impact and improve patient well-being.Comprehensive AssessmentThe initial step in nursing care for hypertension involves a thorough patient assessment. It includes evaluating symptoms such as headaches, dizziness, blurred vision, and previous hypertension episodes.
30
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
41
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
3.0K
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
56